Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Sample Preparation Tools

By Drug Discovery Trends Editor | February 3, 2009

Biotage Sample Preparation ToolsBiotage announced the showcasing of ISOLUTE SLE+ and EVOLUTE at booth 3673 at Pittcon 2009.

ISOLUTE SLE+ Supported Liquid Extraction plates, are rapidly replacing traditional protein precipitation, liquid-liquid extraction, and solid phase extraction protocols because chemists are able to develop methods quickly with analyte recovery and well-to-well reproducibility, according to Biotage. Problems such as emulsion formulation and automated pipetting of liquid layers are also avoided, as the two phases do not come into direct contact. The ISOLUTE SLE+ mechanism is robust and eliminates all off-line steps, cutting sample preparation time in half.

Also on view at Pittcon will be the EVOLUTE series of sample preparation products for the simple and fast removal of phospholipids, salts, and proteins in bioanalytical samples. These high-performance products allow scientists to use a generic approach for a wide range of compounds, thereby reducing method development time while producing clean extracts, according to the company.

EVOLUTE ABN is an advanced water-wettable polymer-based sorbent that extracts acidic, basic, and neutral analytes from biological fluids and other aqueous matrices. Developed for analyte quantification by LC-MS/MS, EVOLUTE ABN’s optimized pore structure minimizes the retention of high molecular weight endogenous materials present in complex sample matrices.

EVOLUTE CX is a mixed-mode resin-based SPE sorbent that extracts a wide range of basic drugs from biological fluid samples. EVOLUTE CX removes matrix components such as proteins, salts, non-ionizable interferences, and phospholipids, delivering cleaner extracts with reproducible recoveries for accurate quantitation.

Visit Biotage at booth 3673 at Pittcon 2009.

www.biotage.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE